Switching back from infliximab biosimilar SB2 to reference infliximab (Remicade) did not affect clinical disease activity or ...

Workplace trends have evolved significantly over the years, from focusing on compliance to cultivating inclusive work cultures that value individuality. These advances become clearer with firms taking ...

The good of diversity must not be jettisoned from the workplace or eliminated from core American values in one sweeping move.